Biocon's founder Kiran Mazumdar-Shaw has made a groundbreaking announcement, pledging her niece Claire Mazumdar as her heir apparent. The transition plan is designed for a slow handover while Mazumdar-Shaw remains at the helm.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/VeLKuyd
via IFTTT
-
Lilly's Mounjaro has rapidly become the second-highest selling drug in India's pharmaceutical market, achieving ₹233 crore in sales ...
-
Acquista ********, Ossicodone, Ketamina, Ozempic (WhatsApp: +31616337954) I nostri prodotti hanno una purezza del 98-99%. E-mail di cont...
-
The Indian Pharmaceutical Alliance lauds the upcoming GST reforms, effective Monday, as a transformative step towards affordable healthcare....
Search This Blog
Powered by Blogger.
Blog Archive
-
▼
2026
(274)
-
▼
May
(9)
- Kiran Mazumdar-Shaw picks niece Claire as successo...
- Emcure eyes India growth, global deals amid strong...
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw be...
- Biocon’s Kiran Mazumdar-Shaw chooses niece Claire ...
- Pharma exports surpass $31 billion in FY26 despite...
- Carlyle acquires Knack RCM and Equalize RCM to cre...
- Two separate venues for pharma industry expos in D...
- Bombay HC backs GSK in Paxil trademark row against...
- Aurobindo Pharma arm CuraTeQ gets Health Canada no...
-
▼
May
(9)
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment